| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21947-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20820 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20737 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20821 | |||
![Western Blot: OX40/TNFRSF4 Antibody (SR1764) [NBP3-21947] - Western blot analysis using NBP3-21947 in Human fetal spleen lysate.](http://images.novusbio.com/fullsize/nbp3-21947_rabbit-ox40-tnfrsf4-mab-sr1764-57202317161894.jpg "Western Blot: OX40/TNFRSF4 Antibody (SR1764) [NBP3-21947] - Western blot analysis using NBP3-21947 in Human fetal spleen lysate.")
![Western Blot: AICDA Antibody [H00057379-D01P] - Analysis of AICDA expression in transfected 293T cell line by AICDA polyclonal antibody.Lane 1: AICDA transfected lysate(24.00 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/AICDA-Antibody-Western-Blot-H00057379-D01P-img0002.jpg "Western Blot: AICDA Antibody [H00057379-D01P] - Analysis of AICDA expression in transfected 293T cell line by AICDA polyclonal antibody.Lane 1: AICDA transfected lysate(24.00 KDa).Lane 2: Non-transfected lysate.")
![Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.](http://images.novusbio.com/fullsize/IL-21-Antibody-MT216G-21-3m-Neutralization-NBP3-18290-img0001.jpg "Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.")
![Western Blot: AICDA Peptide [NBP1-77235PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C](http://images.novusbio.com/fullsize/AICDA-Peptide-Western-Blot-NBP1-77235PEP-img0001.jpg "Western Blot: AICDA Peptide [NBP1-77235PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C")
![Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Validation in Human HL-60 Cell Lysate. Loading: 15 ug of lysates per lane.Antibodies: IL-21 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.](http://images.novusbio.com/fullsize/nbp1-76740pep_il-21-antibody-blocking-peptide-2711202419251583.jpg "Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Validation in Human HL-60 Cell Lysate. Loading: 15 ug of lysates per lane.Antibodies: IL-21 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.")